Dr. Idris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Boston, MA 02114Phone+1 617-726-8707
Summary
- Immunologist and Pediatric Infectious Disease specialist with extensive research and clinical experience committed to medical application of science discovery to alleviate suffering in developing countries.
Education & Training
Children's National Hospital/George Washington UniversityFellowship, Pediatric Infectious Diseases, 2013 - 2015
Emory University School of MedicineResidency, Pediatrics, 2001 - 2004
Icahn School of Medicine at Mount SinaiClass of 2001
Mount Sinai School of MedicinePh.D., Immunology, 1999- Massachusetts Institute of TechnologyB.Sc., Biology, 1987 - 1991
Certifications & Licensure
MA State Medical License 2020 - 2025
DC State Medical License 2013 - 2022
VA State Medical License 2007 - 2016
GA State Medical License 2003 - 2009
FL State Medical License 2004 - 2008- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Infectious Diseases
Awards, Honors, & Recognition
- The Wandra L. Jones-Phillips Compassionate Caregiver Award Emory University Division of Neonatology, 2003
- Jeffery Modell Prize for Excellence in Immunology Mount Sinai School of Medicine, 2001
- Fellow (FAAP) American Academy of Pediatrics
Publications & Presentations
PubMed
- 154 citationsA human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasiteNeville K. Kisalu, Azza H. Idris, Connor Weidle, Yevel Flores-Garcia, Barbara J. Flynn
Nature Medicine. 2018-03-19 - 19 citationsVaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodies.Sven Kratochvil, Chen-Hsiang Shen, Ying-Cing Lin, Kai Xu, Usha Nair
Immunity. 2021-11-16 - 115 citationsAtypical B cells are part of an alternative lineage of B cells that participates in responses to vaccination and infection in humans.Henry J. Sutton, Racheal Aye, Azza H. Idris, Rachel Vistein, Eunice Nduati
Cell Reports. 2021-02-09
Journal Articles
- Murine natural killer cell activation receptorsSmith HR, Idris AH, Yokoyama WM, Immunol Rev, 1/1/2001
- The natural killer gene complex genetic locus Chok encodes Ly-49D, a target recognition receptor that activates natural killingIdris AH, Smith HR, Mason LH, Ortaldo JR, Scalzo AA, Yokoyama WM, Proc Natl Acad Sci U S A, 1/1/1999
- Close genetic linkage of Chok with the NKC-linked loci Cd94, Ly49, and Cmv1 on mouse chromosome 6Idris AH, Scalzo AA, Yokoyama WM, Immunogenetics, 1/1/1999
- Join now to see all
Abstracts/Posters
- Identification of the Chok gene product that regulates natural killing.Idris AH, Smith HRC, Ortaldo JR, Scalzo AA, Yokoyama, WM, FASEB J, FASEB, ASBMB/ASIP/AAI Joint Meeting, Washington, DC, 1/17/1999
- A genetic locus controlling tumor killing maps to the NKC.Idris AH, Scalzo AA, Yokoyama, WM, J Allergy Clin Immunol, AAAI, AAI, CIS Joint Meeting, San Francisco, CA, 1/21/1997
- Genetically determined capacity of natural killer cells to lyse tumor targets.Idris AH, Yokoyama, WM, FASEB J, New Orleans, LA, 1/2/1996
Professional Memberships
- Fellow
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
